文献速递心血管US

乳头肌不同步介导的功能性二尖瓣反流:机制探讨与心脏再同步化治疗的调节作用

Papillary Muscle Dyssynchrony-Mediated Functional Mitral Regurgitation: Mechanistic Insights and Modulation by Cardiac Resynchronization.
PubMed 文献 · JACC Cardiovasc Imaging · 2018-08-15

本研究纳入269例伴传导延迟的射血分数降低的慢性心力衰竭患者,用超声综合评估不同步。重度功能性二尖瓣反流患者的乳头肌间纵向不同步显著大于中度、无或轻度反流者,且与反流容积和缩流颈宽度相关。心脏再同步化治疗恢复乳头肌同步性与反流改善相关,反流改善者8年随访预后更好(校正HR 0.41,95%CI 0.18–0.91,P=0.028)。

要点

  • 重度功能性二尖瓣反流患者乳头肌间纵向不同步为160 ms(IQR 120–200 ms),显著大于中度(70 ms,IQR 40–110 ms)及无或轻度反流者(60 ms,IQR 30–100 ms),P<0.001。
  • 乳头肌间不同步与反流容积(r=0.50,P<0.001)和缩流颈宽度(r=0.49,P<0.001)相关。
  • 心脏再同步化治疗后乳头肌纵向同步性恢复与反流容积(r=0.46,P<0.001)和缩流颈宽度(r=0.58,P<0.001)降低相关。

核心结论

  • 室内不同步导致乳头肌附着壁收缩不均,对功能性二尖瓣反流产生不良影响;心脏再同步化治疗可有效恢复乳头肌间平衡,形成瓣叶膨隆程度更轻的构型,从而产生有临床意义的反流减少;不同步介导的功能性二尖瓣反流中乳头肌同步性的恢复转化为显著更好的预后。

研究设计与样本

  • 研究纳入269例伴传导延迟的射血分数降低的慢性心力衰竭患者,采用互补超声技术全面评估不同步。

关键影像表现/征象

  • 重度功能性二尖瓣反流患者乳头肌间纵向不同步为160 ms(IQR 120–200 ms)。
  • 中度功能性二尖瓣反流患者乳头肌间纵向不同步为70 ms(IQR 40–110 ms)。
  • 无或轻度功能性二尖瓣反流患者乳头肌间纵向不同步为60 ms(IQR 30–100 ms)。
  • 重度组乳头肌间纵向不同步显著大于中度及无或轻度组(P<0.001)。

诊断标准与关键数值

  • 乳头肌间纵向不同步与反流容积相关(r=0.50,P<0.001)。
  • 乳头肌间纵向不同步与缩流颈宽度相关(r=0.49,P<0.001)。
  • 心脏再同步化治疗后乳头肌纵向同步性恢复与反流容积降低相关(r=0.46,P<0.001)。
  • 心脏再同步化治疗后乳头肌纵向同步性恢复与缩流颈宽度降低相关(r=0.58,P<0.001)。
  • 功能性二尖瓣反流改善与乳头肌间径向不同步改善(P=0.006)及纵向不同步改善(P<0.001)相关。

临床应用与阅片要点

  • 不同步介导的功能性二尖瓣反流改善者较反流未改善者8年随访预后更好(校正HR 0.41,95%CI 0.18–0.91,P=0.028)。
  • 对左束支传导阻滞进行校正后,结果几乎不变。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study sought to define interpapillary muscle dyssynchrony as a major contributing factor in functional mitral regurgitation (FMR) and prove the reversibility of FMR by interpapillary muscle resynchronization.

BACKGROUND: Mechanistic features of FMR include papillary muscle displacement due to left ventricular remodeling. Intraventricular conduction delay might further augment this condition by introducing interpapillary muscle dyssynchrony.

METHODS: We enrolled 269 chronic heart failure with reduced ejection fraction patients with conduction delay and comprehensively assessed dyssynchrony by complementary echocardiographic techniques covering the entire spectrum of dyssynchrony.

RESULTS: Patients with severe FMR had markedly increased interpapillary longitudinal dyssynchrony (160 ms [interquartile range (IQR): 120 to 200 ms]) compared with those with moderate (70 ms [IQR: 40 to 110 ms]), no, or mild FMR (60 ms [IQR: 30 to 100 ms]; p < 0.001). Increased interpapillary muscle dyssynchrony was correlated with regurgitant volume (r = 0.50; p < 0.001) and vena contracta width (r = 0.49; p < 0.001). Restoration of longitudinal papillary muscle synchronicity by cardiac resynchronization therapy was correlated with FMR regression, as reflected by the reduction in regurgitant volume (r = 0.46; p < 0.001) and vena contracta width (r = 0.58; p < 0.001). Conversely, the improvement of FMR was associated with improved interpapillary radial (p = 0.006) and longitudinal (p < 0.001) dyssynchrony. The improvement of dyssynchrony-mediated FMR signified a better prognosis compared with no improvement in FMR during the 8-year follow-up period even after comprehensive adjustment by a bootstrap-selected confounder model (adjusted hazard ratio: 0.41; 95% confidence interval: 0.18 to 0.91; p = 0.028). The results remained virtually unchanged after adjustment for left bundle branch block.

CONCLUSIONS: Intraventricular dyssynchrony introduces unequal contraction by papillary muscle bearing walls, which has an adverse effect on FMR. Cardiac resynchronization therapy can effectively restore interpapillary balance and thus create a less tented leaflet configuration, resulting in a clinically meaningful reduction of FMR. The restoration of papillary muscle synchronicity in dyssynchrony-mediated FMR translates into a significantly better prognosis.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Bartko PE, Arfsten H, Heitzinger G, et al. Papillary Muscle Dyssynchrony-Mediated Functional Mitral Regurgitation: Mechanistic Insights and Modulation by Cardiac Resynchronization. JACC Cardiovasc Imaging. 2018. PMID: 30121264. doi:10.1016/j.jcmg.2018.06.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。